





Yale University
Dept. of Psychiatry
300 George Street
New Haven, CT
06511 USA
Tel: 203-785-2117

|
|
Clinical and Basic
Neuroscience Research
Training Program in Psychiatry
Affective Disorders Research
Current research centers on the role of the serotonergic and excitatory
amino acid systems in affective disorders, including major depression
and mania, as well as on the mechanism of antidepressant action. Lithium
augmentation for unremitting depression has been one clinical innovation
derived from this research.
Basic science researchers are simultaneously bringing sophisticated
and sensitive electrophysiological tools (e.g., patch-clamping, single
cell recording, microiontophoresis) to bear on the study of serotonergic
neurotransmission and its regulation by drug treatments. In addition,
a new and exciting program of research is examining the effects of stress
on the hypothalamic-pituitary-adrenal axis, corticotrophin releasing factor,
and neurotrophic and growth factors, as well as their regulation by antidepressant
treatments. The potent effects of stress in suppressing brain-derived
neurotrophic factor (BDNF) and the ability of electroconvulsive seizures
and chemical antidepressants to increase BDNF are being elucidated in
rats, and converging with corresponding clinical studies of ECT effects
in depressed subjects.

|
Clinical investigators, using these findings, are continually
evaluating potentially synergistic pharmacotherapies which simultaneously
influence neurotransmission via distinct extracellular and intracellular
mechanisms. In addition, research into novel somatic therapies, such a
repetitive transcranial magnetic stimulation, is being conducted.
Neuroimaging Researchers, using newly devloped neuroreceptor
imaging methods, such as PET and SPECT, are measuring serotonin transporter
levels in the brains of depressed patients, as well as their occupancy
by antidepressant doses of selective serotonin reuptake inhibitors (e.g.,
fluoxetine, paroxetine, sertraline). Newly developed tracers for the serotonin
receptor subtypes, includeing 5HT-2 and 5HT1A are also underway.
Faculty related to Affective Disorder Research
Duman
Blumberg
Epperson
Kaufman
Southwick
Sanacora

Last modified:
July 6, 2004


 |